Related Experiment Video
Updated: May 20, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Robust inference in discrete hazard models for randomized clinical trials
Vinh Q Nguyen1, Daniel L Gillen
1Department of Statistics, University of California, Irvine, CA, USA. vqnguyen@uci.edu
Abstract:
Time-to-event data in which failures are only assessed at discrete time points are common in many clinical trials. Examples include oncology studies where events are observed through periodic screenings such as radiographic scans. When the survival endpoint is acknowledged to be discrete, common methods for the analysis of observed failure times include the discrete hazard models (e.g., the discrete-time proportional hazards and the continuation ratio model) and the proportional odds model. In this manuscript, we consider estimation of a marginal treatment effect in discrete hazard models where the constant treatment effect assumption is violated. We demonstrate that the estimator resulting from these discrete hazard models is consistent for a parameter that depends on the underlying censoring distribution. An estimator that removes the dependence on the censoring mechanism is proposed and its asymptotic distribution is derived. Basing inference on the proposed estimator allows for statistical inference that is scientifically meaningful and reproducible. Simulation is used to assess the performance of the presented methodology in finite samples.
Related Concept Videos
Hazard Ratio
For example, in a clinical trial evaluating a...
Hazard Rate
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Randomized Experiments
Simple randomization
Simple...

